Table 5 Univariable and multivariable analyses of prognostic value of TROP-2 expression (continuous and categorical).

From: Correlation of TROP-2 expression with clinical–pathological characteristics and outcome in triple-negative breast cancer

Distribution TROP-2 expression

Analysis

Outcome

Hazard ratio (95% CI)

p-value

Continuous (+ 10 units H-score)

Univariable

BCSS

0.978 (0.953;1.003)

0.089

DRFI

0.978 (0.954;1.002)

0.075

IDFS

0.982 (0.964;1.000)

0.051

Multivariable

BCSS

0.983 (0.957;1.009)

0.205

DRFI

0.982 (0.958;1.007)

0.165

IDFS

0.981 (0.963;1.000)

0.049

Categorical (global test)

Univariable

BCSS

NA

0.434

DRFI

0.415

IDFS

0.235

Multivariable

BCSS

0.433

DRFI

0.472

IDFS

0.264

  1. HR hazard ratio, CI confidence interval, HR > (<)1 increased(decreased) risk with increasing TROP2 level, corrected for: age, N-positive, T-stage, grade, AR percentage, NA not available.
Back to article page